We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300999:SZSEYihai Kerry Arawana Holdings Co. Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥31.11

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Yihai Kerry Arawana trades around CNY 31.1, just above its 200‑day SMA of 30.59 and comfortably above the 20‑day SMA of 29.99, indicating a modest upward bias. The RSI sits at 58, well below overbought levels, while the MACD histogram is positive, supporting a bullish technical backdrop. Volume is on an increasing trend, and the stock is positioned midway between a support near 28.4 and resistance around 33.6, offering upside potential of roughly 10% as reflected in the upside/downside estimate. Fundamentally, the company faces challenges: revenue has slipped 4% year‑over‑year, operating margins are thin at 2.7%, and ROE is only 3.2%, while the debt‑to‑equity ratio is high at nearly 90%, suggesting a leveraged balance sheet. The trailing PE of 44× is markedly above the market average, even though the forward PE contracts to about 24×, and the price‑to‑sales ratio of 0.69 hints at a relatively cheap sales multiple. The dividend payout is modest at 0.35% with a low payout ratio of 16%, making the current yield appear sustainable. Risk‑adjusted returns are mixed: a very low beta (≈0.08) points to limited market sensitivity, yet 30‑day volatility exceeds 36%, and the consumer‑defensive sector typically offers stability but is subject to Chinese food‑safety and policy scrutiny. Overall, the stock presents a borderline overvalued profile with a value‑oriented tilt, modest dividend appeal, and a technical environment that favors cautious optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and SMA alignment
  • Near‑term resistance at 33.6 limiting upside
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Improving forward PE and sales multiple
  • Sustainable dividend payout
  • Increasing volume supporting price appreciation

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Weak revenue growth and thin margins
  • Elevated debt‑to‑equity ratio
  • Stable consumer‑defensive sector backdrop

Key Metrics & Analysis

Financial Health

Revenue Growth-4.00%
Profit Margin1.29%
P/E Ratio43.8
ROE3.17%
Debt/Equity89.70
P/B Ratio1.8

Technical Analysis

TrendNeutral
RSI58.1
SupportCN¥28.40
ResistanceCN¥33.61
MA 20CN¥29.99
MA 50CN¥29.76
MA 200CN¥30.59
MACDBullish
VolumeIncreasing
Fear & Greed Index81.45

Valuation

Target PriceCN¥34.20
Upside/Downside9.93%
GradeOvervalued
TypeValue
Dividend Yield0.35%

Risk Assessment

Beta0.08
Volatility36.81%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.